Abstract #3934

Multiparametric MRI as a biomarker of response to neoadjuvant second-generation hormone therapy for localized prostate cancer- a pilot study

Fiona Fennessy^1,2, Andriy Fedorov¹, Mark Vangel³, Robert Mulkern⁴, Rosina Lis⁵, Maria Tretiakova⁶, Clare Tempany¹, and Mary Ellen Taplin⁷

¹Radiology, Brigham and Women's Hospital, Boston, MA, United States, ²Dana Farber Cancer Institute, Boston, MA, United States, ³Radiology, Massachusetts General Hospital, Boston, MA, United States, ⁴Radiology, Children's Hospital Boston, Boston, MA, United States, ⁵Pathology, Dana Farber Cancer Institute, Boston, MA, United States, ⁶Pathology, University of Washington, Seattle, WA, United States, ⁷Oncology, Dana Farber Cancer Institute, Boston, MA, United States

Advanced prostate cancer (PCa) is driven by androgen receptor (AR) signaling, and as such the AR is an important therapeutic target to prevent PCa progression. The aim of this pilot study was to explore a role for prostate multiparametric MRI (mpMRI) as a biomarker for treatment response of localized prostate cancer to neoadjuvant treatment with the second-generation AR inhibitor enzalutamide. We demonstrate that quantitative mpMRI may play an important role as a biomarker of response to neoadjuvant treatment of localized PCa, and MRI-based tumor volumetrics may act as a surrogate for RCB at prostatectomy. These findings are worthy of investigation in a larger clinical setting.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.